Trials / Conditions / Sarcoidosis, Pulmonary

Sarcoidosis, Pulmonary

27 registered clinical trials studyying Sarcoidosis, Pulmonary — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Diagnostic Value of EBUS-Guided Transbronchial Mediastinal Cryobiopsy Versus Conventional Bronchoscopic Approa NCT07246876	China-Japan Friendship Hospital	N/A
Withdrawn	Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis NCT05910554	University of Maryland, Baltimore	Phase 2
Recruiting	Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis NCT05841758	Hospices Civils de Lyon	Phase 4
Recruiting	RCT of Nintedanib in Fibrotic Sarcoidosis NCT06479603	Post Graduate Institute of Medical Education and Research, Chandigarh	Phase 4
Recruiting	Feasibility of Semaglutide in Advanced Lung Disease NCT05746039	University of Pennsylvania	Phase 1 / Phase 2
Active Not Recruiting	the PHENOSAR Trial: Use of Antibiotics in Treatment of Sarcoidosis NCT05291468	St. Antonius Hospital	N/A
Recruiting	Risk Indicators of Sarcoidosis Evolution-Unified Protocol NCT05567133	University of California, San Francisco	—
Completed	Peripheral Airway Biopsy in Sarcoidosis NCT05759221	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	N/A
Terminated	A Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary Sarcoidosis NCT05314517	Kinevant Sciences GmbH	Phase 2
Completed	Diagnostic Yield of Intranodal Forceps Biopsies in Mediastinal Adenopathy NCT05374447	George Washington University	N/A
Completed	An RCT of NBI vs. White Light Guided Endobronchial Biopsy in Suspected Sarcoidosis NCT05311150	Post Graduate Institute of Medical Education and Research, Chandigarh	N/A
Unknown	Endobronchial Ultrasound Strain Elastography in Sarcoidosis NCT04895111	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	—
Active Not Recruiting	Effectiveness of Methotrexate Versus Prednisone as First-line Therapy for Pulmonary Sarcoidosis NCT04314193	Erasmus Medical Center	Phase 4
Completed	Azithromycin a Treatment for Pulmonary Sarcoidosis NCT04020380	Hull University Teaching Hospitals NHS Trust	Phase 2
Completed	Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis NCT03793439	Oregon Health and Science University	Phase 1
Completed	A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulm NCT03727451	Bellerophon	Phase 2
Unknown	Feasibility & Effect of a Tele-rehabilitation Program in Pulmonary Sarcoidosis Pulmonary Sarcoidosis NCT03914027	Aarhus University Hospital	N/A
Recruiting	Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease NCT03455686	McMaster University	N/A
Completed	Acthar Gel in Participants With Pulmonary Sarcoidosis NCT03320070	Mallinckrodt	Phase 4
Completed	A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subj NCT03324503	Celgene	N/A
Completed	The Role of Physical Activity and Diet Within Pulmonary Sarcoidosis NCT03336736	Kingston University	—
Unknown	Pirfenidone for Progressive Fibrotic Sarcoidosis NCT03260556	University of Cincinnati	Phase 4
Completed	SARCOLOWDOSE : Ultra-low Dose CT Scan and MRI in Thoracic Sarcoidosis NCT03140644	Rennes University Hospital	N/A
Completed	Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung Disease NCT04803617	Habibedurdu	—
Unknown	Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis NCT03145922	National Jewish Health	—
Completed	The Diagnostic and Prognostic Role of SAA in Intrathoracic Sarcoidosis NCT05811962	University Medical Centre Ljubljana	—
Completed	Atorvastatin to Treat Pulmonary Sarcoidosis NCT00279708	National Heart, Lung, and Blood Institute (NHLBI)	Phase 2